Skip to content

Eikon Therapeutics, Inc. EIKN Operating Lease Liabilities

Operating Lease Liabilities at other companies

Unifirst logo
UnifirstUNF
$59.67M+11.2%
MYR Group logo
MYR GroupMYRG
$37.6M+24.7%
Dave, Inc. logo
Dave, Inc.DAVE
$124K-34.4%
Alkami Technology, Inc. logo
Alkami Technology, Inc.ALKT
$19.33M+14.3%
Griffon logo
GriffonGFF
$55.2M-61.3%
Repligen logo
RepligenRGEN
$119.96M-13.7%

Other financials

Income statement

See full
Operating income-$87.3M-22.3%
Net income-$83.0M-21.6%
EPS (diluted)-$2.46+90.9%

Balance sheet

See full
Cash & equivalents$161.2M-21.2%
Total debt$254.8M
Total equity$550.7M+186%
Total assets$850.8M

Cash flow

See full
Operating cash flow-$89.8M-64.7%
CapEx$262.0K-98.8%
Free cash flow-$90.1M-17.1%

Valuation

See full
Market cap$521.35M

Where this comes from

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eikon Therapeutics, Inc. 's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eikon Therapeutics, Inc. 's operating lease liabilities?
Eikon Therapeutics, Inc. (EIKN) reported operating lease liabilities of $245.09M in Q1 2026.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.